# Phase I Trial of Tanibirumab in Advanced or Metastatic Cancer

> **NCT01660360** · PHASE1 · COMPLETED · sponsor: **PharmAbcine** · enrollment: 26 (actual)

## Conditions studied

- Advanced Cancer
- Metastatic Cancer

## Interventions

- **BIOLOGICAL:** Tanibirumab

## Key facts

- **NCT ID:** NCT01660360
- **Lead sponsor:** PharmAbcine
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-11
- **Primary completion:** 2013-09
- **Final completion:** 2013-09
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2014-01-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01660360

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01660360, "Phase I Trial of Tanibirumab in Advanced or Metastatic Cancer". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01660360. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*